Dr. Jayanthi Koneru presented the DEEP abstract results today at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a>, showcasing the long-term effectiveness and durability of Hybrid Ablation in treating Advanced Afib patients.

The DEEP Trial revealed that 71.6% of patients with Advanced Afib disease* had no recurring atrial arrhythmias** one year after the procedure, and 62.4% remained arrhythmia-free two years post-procedure.

*Persistent or long-standing persistent Afib
**Afib, atrial flutter, atrial tachycardia episodes >30 sec, off anti-arrhythmic drugs (AAD, if reported) and regardless of AAD status.